Daiwa Securities Group
SANA icon

Daiwa Securities Group’s Sana Biotechnology SANA Stock Holding History

Daiwa Securities Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-767
Closed -$3K – 1400
2025
Q4 		$3K Hold
767
– – ﹤0.01% 1285
2025
Q3 		$3K Hold
767
– – ﹤0.01% 1249
2025
Q2 		$2K Hold
767
– – ﹤0.01% 1225
2025
Q1 		$1K Hold
767
– – ﹤0.01% 1250
2024
Q4 		$1K Hold
767
– – ﹤0.01% 1267
2024
Q3 		$3K Hold
767
– – ﹤0.01% 1205
2024
Q2 		$4K Hold
767
– – ﹤0.01% 1216
2024
Q1 		$8K Hold
767
– – ﹤0.01% 1182
2023
Q4 		$3K Hold
767
– – ﹤0.01% 1253
2023
Q3 		$3K Hold
767
– – ﹤0.01% 1204
2023
Q2 		$5K Hold
767
– – ﹤0.01% 1186
2023
Q1 		$3K Hold
767
– – ﹤0.01% 1195
2022
Q4 		$3K Buy
767
+216
+39% +$1.06K ﹤0.01% 1205
2022
Q3 		$3K Hold
551
– – ﹤0.01% 1206
2022
Q2 		$4K Hold
551
– – ﹤0.01% 1189
2022
Q1 		$5K Hold
551
– – ﹤0.01% 1178
2021
Q4 		$9K Buy
+551
New +$10.6K ﹤0.01% 1159

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Daiwa Securities Group's SANA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 767 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in SANA in Q4 2021 and held it in 17 quarters. The position peaked at $9K in Q4 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 767 Sana Biotechnology shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Sana Biotechnology in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Sana Biotechnology position peaked at $9K in Q4 2021.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.